메뉴 건너뛰기
International Urology and Nephrology
Volumn 36, Issue 2, 2004, Pages 287-288
Rifampicin sparing treatment protocols in posttransplant tuberculosis
Author keywords

Cyclosporine; Kidney transplantation; Rifampicin; Tuberculosis
Indexed keywords

ANTIMYCOBACTERIAL AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOCHROME P450; ETHAMBUTOL; GATIFLOXACIN; ISONIAZID; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TACROLIMUS; TUBERCULOSTATIC AGENT;
EID: 3242694203     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:UROL.0000034616.17935.98     Document Type: Note
Times cited : (6)
References (8)
  • 1
    • 0242721547 scopus 로고    scopus 로고
    • Tuberculosis following organ transplantation
    • Chugh KS, Jha V. Tuberculosis following organ transplantation. Transplantation Proc 2003; 35: 2676-2677.
    • (2003) Transplantation Proc. , vol.35 , pp. 2676-2677
    • Chugh, K.S.1    Jha, V.2
  • 2
    • 0141990811 scopus 로고    scopus 로고
    • Tuberculosis in renal transplant recipients: Rifampicin sparing treatment protocol
    • Vachharajani TJ, Oza UG, Phadke AG, Kirpalani AL. Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol. Int Urol Nephrol 2002; 34: 551-553.
    • (2002) Int. Urol. Nephrol. , vol.34 , pp. 551-553
    • Vachharajani, T.J.1    Oza, U.G.2    Phadke, A.G.3    Kirpalani, A.L.4
  • 3
    • 0030038844 scopus 로고    scopus 로고
    • The high incidence of tuberculosis among renal transplant recipients in India
    • Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-215.
    • (1996) Transplantation , vol.61 , pp. 211-215
    • Sakhuja, V.1    Jha, V.2    Varma, P.P.3    Joshi, K.4    Chugh, K.S.5
  • 4
    • 0032746360 scopus 로고    scopus 로고
    • Successful management of pulmonary tuberculosis in renal allograft recipients in a single center
    • Jha V, Sakhuja V, Gupta D et al. Successful management of pulmonary tuberculosis in renal allograft recipients in a single center. Kidney Int 1999; 56: 1944-1950.
    • (1999) Kidney Int. , vol.56 , pp. 1944-1950
    • Jha, V.1    Sakhuja, V.2    Gupta, D.3
  • 5
    • 0037311481 scopus 로고    scopus 로고
    • Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis
    • Hu Y, Coates AR, Mitchison DA. Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 653-657.
    • (2003) Antimicrob. Agents Chemother. , vol.47 , pp. 653-657
    • Hu, Y.1    Coates, A.R.2    Mitchison, D.A.3
  • 6
    • 0029761216 scopus 로고    scopus 로고
    • In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages
    • Rastogi N, Labrousse V, Goh KS. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr Microbiol 1996; 33: 167-175.
    • (1996) Curr. Microbiol. , vol.33 , pp. 167-175
    • Rastogi, N.1    Labrousse, V.2    Goh, K.S.3
  • 7
    • 0036556506 scopus 로고    scopus 로고
    • Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs
    • Tomioka H, Sato K, Shimizu T, Sano C. Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs. J Infect 2002; 44: 160-165.
    • (2002) J. Infect. , vol.44 , pp. 160-165
    • Tomioka, H.1    Sato, K.2    Shimizu, T.3    Sano, C.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.